SCHEMBL29914608

SCHEMBL29914608

CN([C@H]1CCN(c2cccc(F)c2F)C1)S(C)(=O)=O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 3/20 0.43
▸ NOTUM Q6P988 2/20 0.43
▸ PDE10A Q9Y233 1/20 0.41
▸ PIK3CD O00329 4/20 0.40
▸ PIK3R1 P27986 4/20 0.40
▸ PIK3CA P42336 4/20 0.40
▸ PIK3CB P42338 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HTR2A P28223 2/20 0.38
▸ HTR2C P28335 2/20 0.38
▸ PIM1 P11309 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24681006 1.00 NPY5R (0.43) NPY5RNOTUMPDE10APIK3CDPIK3R1
SCHEMBL29914569 1.00 NPY5R (0.43) NPY5RNOTUMPDE10APIK3CDPIK3R1
SCHEMBL24681623 1.00 NPY5R (0.43) NPY5RNOTUMPDE10APIK3CDPIK3R1
SCHEMBL29914554 0.84 CHEK2 (0.46) NPY5RNOTUMPIM1PIM3PIM2
SCHEMBL24681535 0.84 CHEK2 (0.46) NPY5RNOTUMPIM1PIM3PIM2
SCHEMBL24680787 0.81 PDE10A (0.38) NPY5RPDE10APIK3CDPIK3R1PIK3CA
SCHEMBL29914530 0.81 PDE10A (0.38) NPY5RPDE10APIK3CDPIK3R1PIK3CA
SCHEMBL24681279 0.81 PDE10A (0.38) NPY5RPDE10APIK3CDPIK3R1PIK3CA
SCHEMBL29914526 0.81 PDE10A (0.38) NPY5RPDE10APIK3CDPIK3R1PIK3CA
SCHEMBL25966654 0.80 HTR2A (0.41) NPY5RNOTUMPIK3CDPIK3R1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226667-A1 SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 — — WO disclosed
Send feedback